bioRxiv Science⌕ Search

Biology subjects

Figgins, M. D.

Publications and source records attributed to Figgins, M. D..

2 recordsLinked to original sources

antigen-prime: Simulating coupled genetic and antigenic evolution of influenza virus

Seasonal influenza virus undergoes rapid antigenic drift to escape population immunity. Computational methods can be used to organize viral genetic diversity into antigenically similar variants and estimate variantspecific growth rates. However, benchmarking these methods is challenging because it can be difficult to accurately quantify antigenicity and growth rates in nature. Simulating viral evolution using defined selective pressures can provide ground-truth data for benchmarking. But, existing simulators do not link genetic sequences to antigenic phenotypes under selection from host populations. Here, we present a forward-time epidemic simulator called antigen-prime that links these factors. We use it to simulate viral evolution over 30 years and validate the simulation recapitulates genetic and antigenic patterns observed in natural influenza evolution. We then use the simulated data to benchmark methods for assigning variants and estimating their growth rates. We evaluated a sequencebased and a phylogenetics-based method for variant assignment, finding the former was slightly more effective at separating viruses into antigenically distinct groups. We also evaluated methods for estimating variant growth rates in one-year sliding windows. Estimates were accurate in most windows, but highly inaccurate in several others. Examining higherror windows revealed several examples of a previously unreported failure mode. In all, antigen-prime provides a simulation framework to benchmark models of influenza evolution, and could be used to help guide future development of these models. The source code is openly available at https://github.com/matsengrp/antigen-prime.

bioinformatics↗

High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strains

Human influenza viruses rapidly acquire mutations in their hemagglutinin (HA) protein that erode neutralization by antibodies from prior exposures. Here, we use a sequencing-based assay to measure neutralization titers for 78 recent H3N2 HA strains against a large set of children and adult sera, measuring [~]10,000 total titers. There is substantial person-to-person heterogeneity in the titers against different viral strains, both within and across age cohorts. The growth rates of H3N2 strains in the human population in 2023 are highly correlated with the fraction of sera with low titers against each strain. Notably, strain growth rates are less correlated with neutralization titers against pools of human sera, demonstrating the importance of population heterogeneity in shaping viral evolution. Overall, these results suggest that high-throughput neutralization measurements of human sera against many different viral strains can help explain the evolution of human influenza.

evolutionary biology↗